Virginia Retirement Systems’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
Other funds holding TVTX
JT
PA
NAMI
Virginia Retirement Systems's TVTX Position: Q2 2026 in Review
Virginia Retirement Systems increased its Travere Therapeutics (TVTX) stake by 51% in Q2 2026, buying an estimated $403K and bringing the position to 27,000 shares worth $1.53M. The position accounts for 0.01% of the portfolio, ranked #615.
Virginia Retirement Systems first reported a position in TVTX in Q3 2015 and has held it in 18 quarters since. The position peaked at $2.19M in Q3 2017. 321 funds tracked by Wall St. Rank hold TVTX as of Q2 2026.
- Virginia Retirement Systems held 27,000 shares of Travere Therapeutics worth $1.53M as of Q2 2026.
- Virginia Retirement Systems bought 9,100 Travere Therapeutics shares in Q2 2026, an estimated $403K.
- Travere Therapeutics made up 0.01% of Virginia Retirement Systems's portfolio in Q2 2026, its #615 holding.
- Virginia Retirement Systems first reported a position in Travere Therapeutics in Q3 2015 and has held it in 18 quarters since.
- Virginia Retirement Systems's Travere Therapeutics position peaked at $2.19M in Q3 2017.
- 321 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2026.
Based on Virginia Retirement Systems's 13F filing for Q2 2026, filed 25 Aug 2026.